Ethambutol/isoniazid/rifampicin
Ethambutol/isoniazid/rifampicin, also known as ethambutol/isoniazid/rifampin, is a fixed-dose combination medication used to treat tuberculosis.[1] It contains ethambutol, isoniazid, and rifampicin.[1] It is used either along or with other antituberculosis medication.[1] It is taken by mouth.[1] Side effects are those of the underlying medications.[1] Use may not be suitable in children.[1]
| Combination of | |
|---|---|
| ethambutol | anti-tuberculosis medication |
| isoniazid | anti-tuberculosis medication |
| rifampicin | anti-tuberculosis medication |
| Clinical data | |
| ATC code | |
| Identifiers | |
| ChemSpider |
|
It is on the World Health Organization's List of Essential Medicines.[2]
References
- World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. p. 142. hdl:10665/44053. ISBN 9789241547659.
- World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
Big text
[[DEFAULTSORT:Ethambutol Isoniazid Rifampicin}}
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.